Rani Deepa Selvi, Nallari Pratibha, Rani Jhansi, Nizamuddin Sheikh, Seelamneni Thulasamma, Narasimhan Calambur, Thangaraj Kumarasamy
CSIR - Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India.
Department of Genetics, Osmania University, Hyderabad, India.
Cardiology. 2018;141(3):156-166. doi: 10.1159/000495027. Epub 2019 Jan 3.
Myosin is a hexameric contractile protein composed of 2 heavy chains associated with 4 light chains of 2 distinct classes - 2 regulatory light chains (MYL2) and 2 essential light chains (MYL3). The myosin light chains stabilize the long alpha helical neck of the myosin head and regulate the myosin ATPase activities.
Mutations in MYL2 and MYL3 are reported to be associated with cardiomyopathies. However, there is no study available on these genes in Indian cardiomyopathies, and therefore we planned to study them.
For the first time we sequenced MYL2 and MYL3 genes in a total of 248 clinically well-characterized cardiomyopathies consisting of 101 hypertrophic and 147 dilated cases along with 207 healthy controls from south India.
Our study revealed a total of 10 variations - 7 in MYL2 and 3 in MYL3, of which 3 are novel variations observed exclusively in cases. However, the 15 causative missense mutations previously reported are totally absent in our study, which showed that the sequences of MYL2 and MYL3 are highly conserved in Indian cases/controls.
MYL2 and MYL3 mutations are rare and the least cause of cardiomyopathies in Indians.
肌球蛋白是一种六聚体收缩蛋白,由2条重链与4条轻链组成,这4条轻链分为2种不同类型——2条调节性轻链(MYL2)和2条必需轻链(MYL3)。肌球蛋白轻链可稳定肌球蛋白头部的长α螺旋颈部,并调节肌球蛋白ATP酶活性。
据报道,MYL2和MYL3突变与心肌病有关。然而,在印度的心肌病患者中,尚未有关于这些基因的研究,因此我们计划对其进行研究。
我们首次对来自印度南部的248例临床特征明确的心肌病患者(包括101例肥厚型和147例扩张型)以及207名健康对照者的MYL2和MYL3基因进行了测序。
我们的研究共发现了10个变异——MYL2中有7个,MYL3中有3个,其中3个是仅在病例中观察到的新变异。然而,我们的研究中完全没有之前报道的15个致病性错义突变,这表明在印度的病例/对照中,MYL2和MYL3的序列高度保守。
在印度人群中,MYL2和MYL3突变很少见,是心肌病最次要的病因。